National Survey on the Susceptibility ofBacteroides fragilisGroup: Report and Analysis of Trends for 1997–2000
Open Access
- 1 September 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 35 (s1) , S126-S134
- https://doi.org/10.1086/341934
Abstract
The results of a multicenter US survey using the National Committee for Clinical Laboratory Standards currently recommended methodology for measuring in vitro susceptibility of 2673 isolates of Bacteroides fragilis group species were compared from 1997 to 2000. The test panel consisted of 14 antibiotics: 3 carbapenems, 3 β-lactam-β-lactamase inhibitors, 3 cephamycins, 2 fluoroquinolones, clindamycin, chloramphenicol, and metronidazole. Declines in the geometric mean minimum inhibitory concentrations were seen with imipenem, meropenem, ampicillin-sulbactam, and the cephamycins. Increased geometric means were observed with the fluoroquinolones and were usually accompanied by an increase in resistance rates. Bacteroides distasonis shows the highest resistance rates among β-lactam antibiotics, whereas Bacteroides vulgatus shows the highest resistance levels among fluoroquinolones. B. fragilis shows the lowest resistance rates for all antibiotics. All strains were susceptible to chloramphenicol and metronidazole concentrations <8 μg/mL. The data underscore the need for species identification and continued surveillance to monitor resistance patterns.Keywords
This publication has 10 references indexed in Scilit:
- In Vitro Activities of MK-0826 and 16 Other Antimicrobials against Bacteroides fragilis Group StrainsAntimicrobial Agents and Chemotherapy, 2001
- Multicenter Survey of the Changing In Vitro Antimicrobial Susceptibilities of Clinical Isolates of Bacteroides fragilis Group, Prevotella, Fusobacterium, Porphyromonas , and Peptostreptococcus SpeciesAntimicrobial Agents and Chemotherapy, 2001
- Comparative In Vitro Activities of Ertapenem (MK-0826) against 1,001 Anaerobes Isolated from Human Intra-Abdominal InfectionsAntimicrobial Agents and Chemotherapy, 2000
- Antimicrobial Resistance and Clinical Outcome of Bacteroides Bacteremia: Findings of a Multicenter Prospective Observational TrialClinical Infectious Diseases, 2000
- Multicenter Study of In Vitro Susceptibility of the Bacteroides fragilis Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996Antimicrobial Agents and Chemotherapy, 1999
- Activities of New Antimicrobial Agents (Trovafloxacin, Moxifloxacin, Sanfetrinem, and Quinupristin-Dalfopristin) against Bacteroides fragilis Group: Comparison with the Activities of 14 Other AgentsAntimicrobial Agents and Chemotherapy, 1999
- Analysis of Trends in Antimicrobial Resistance Patterns Among Clinical Isolates of Bacteroides fragilis Group Species from 1990 to 1994Clinical Infectious Diseases, 1996
- Clinical Relevance of Susceptibility Testing of Anaerobic BacteriaClinical Infectious Diseases, 1993
- Wound and Intraabdominal Infections: Microbiological Considerations and Approaches to TreatmentClinical Infectious Diseases, 1993
- Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysisAntimicrobial Agents and Chemotherapy, 1992